Velbe Ampoule is a chemotherapy drug used to treat several types of cancer such as lymphoma, leukemia, and testicular cancer. It contains vinblastine, which works to prevent cancer cells from dividing by affecting the microtubules responsible for cell division, which leads to stopping the growth of malignant cells.
Velbe Ampoule is given by intravenous injection under the supervision of a specialized doctor. The patient must be closely monitored during the treatment period because the drug may cause a severe decrease in white blood cells and platelets, which increases the risk of infection and bleeding. It may also cause nausea, constipation, hair loss, and neurological changes. Therefore, it is important to conduct periodic blood tests and regularly evaluate neurological symptoms.